Today: 20 November 2025
Subscribe
Browse Category

Company News News 11 November 2025 - 12 November 2025

Shell’s $2 Billion Nigeria Gas Gamble Ignites LNG Boom Amid $8 B Investment Surge

Shell Stock Price Today (12 Nov 2025): SHEL ADR edges lower as oil slides; London closes at 2,909p amid fresh buyback and Volta Media sale

All figures and news items are for Wednesday, November 12, 2025. Shell stock at a glance (real‑time snapshot) Note: Each U.S. SHEL ADR represents two ordinary shares traded in London/Amsterdam. Nasdaq What moved Shell’s share price today 1) Oil prices dropped on a new OPEC outlook Crude fell sharply after an OPEC report signaled supply and demand could be broadly in balance in 2026, sapping sentiment across energy equities. By early afternoon U.S. time, Brent was down to $62.61 (–3.9%) and WTI to $58.46 (–4.2%). For integrated majors like Shell, lower crude typically pressures earnings expectations for upstream and trading.
12 November 2025
 ·  ·  ·  · 
Nextracker Rebrands as Nextpower: NXT Stock Slips as Company Unveils Power‑Conversion Push and Long‑Term Targets (Nov. 12, 2025)

Nextracker Rebrands as Nextpower: NXT Stock Slips as Company Unveils Power‑Conversion Push and Long‑Term Targets (Nov. 12, 2025)

FREMONT, Calif. — November 12, 2025. Solar‑tracker leader Nextracker Inc. has rebranded as Nextpower Inc., signaling a broader pivot from single components to a fully integrated energy‑technology platform. The move arrives alongside fresh long‑term targets and the launch of a power‑conversion systems (PCS) line slated to begin shipping in 2026. The Nasdaq ticker remains NXT. Business Wire Key takeaways What changed: from Nextracker to Nextpower Management says the new brand captures the company’s evolution “into a full‑platform provider” that connects hardware, software, and services across the design, build, and operate lifecycle of modern power plants. “Our customers want coherent, integrated
12 November 2025
 ·  ·  ·  ·  · 
AT&T Stock Faces Crucial Test: 5G Spectrum Gamble, Fiber Expansion & Earnings Loom

AT&T Stock Today (Nov. 12, 2025): KeyBanc Upgrade Lifts T; NYC Subway 5G Expansion; Data-Breach Settlement Deadline Nears

Published: November 12, 2025 Key takeaways AT&T stock today: price action and context AT&T (NYSE: T) traded around $25.63, up ~1.8% as of 2:39 p.m. ET (19:39:16 UTC). The session range ran $25.25–$25.73 on volume of ~26.4M shares at that time. Market tone was mixed, with tech lagging while broader U.S. equities digested Washington headlines. Reuters The catalyst: KeyBanc turns bullish with a $30 target The day’s biggest stock-specific driver is KeyBanc’s upgrade of AT&T to Overweight and a $30 price target—about 17% above this afternoon’s price—framing the recent pullback as overdone. Analyst Brandon Nispel argues that worries about a
12 November 2025
 ·  ·  ·  ·  · 
Leap Therapeutics (LPTX) Rebrands as “Cypherpunk,” Buys $50M in Zcash; Ticker to Change to CYPH on Nov. 13 — Q3 Results and New $200M ATM Filed (Nov. 12, 2025)

Leap Therapeutics (LPTX) Rebrands as “Cypherpunk,” Buys $50M in Zcash; Ticker to Change to CYPH on Nov. 13 — Q3 Results and New $200M ATM Filed (Nov. 12, 2025)

Leap Therapeutics, Inc. (Nasdaq: LPTX) unveiled a sweeping strategic pivot today: the oncology company is rebranding as Cypherpunk Technologies Inc., has already purchased ~$50 million of Zcash (ZEC) for a new digital‑asset treasury strategy, and will switch its Nasdaq ticker from LPTX to CYPH at the open on Thursday, Nov. 13, 2025. The company also filed fresh SEC documents, including Q3 2025 results and a $200 million at‑the‑market (ATM) equity program with Cantor Fitzgerald. PR Newswire+2SEC+2 What changed — and why it matters Rebrand & crypto‑treasury pivot. In a 7:00 a.m. ET release, the company said it will adopt the
12 November 2025
 ·  ·  ·  ·  ·  · 
BILL Holdings (BILL) Surges as Company Explores a Sale — What Investors Need to Know Today (Nov. 12, 2025)

BILL Holdings (BILL) Surges as Company Explores a Sale — What Investors Need to Know Today (Nov. 12, 2025)

BILL Holdings, Inc. (NYSE: BILL) rallied today after multiple outlets reported the SMB payments platform is weighing strategic options, including a potential sale. Below is a concise rundown of what changed today, why it matters, and what to watch next. What happened today Reports of a strategic review lit a fire under BILL’s stock. Reuters said BILL concluded its shares are undervalued and is exploring a sale; talks remain preliminary with no assurance of a transaction. Bloomberg’s legal desk added that a financial adviser is soliciting interest from larger industry rivals and PE sponsors. The company hasn’t commented on the
12 November 2025
 ·  ·  ·  ·  · 
BigBear.ai (BBAI) Today: Stock Moves, $250M Ask Sage Deal, and Q3 Beat — What Investors Need to Know (Nov 12, 2025)

BigBear.ai (BBAI) Today: Stock Moves, $250M Ask Sage Deal, and Q3 Beat — What Investors Need to Know (Nov 12, 2025)

BigBear.ai (NYSE:BBAI) moves on Q3 results and a $250M Ask Sage acquisition. Here’s what changed today, Nov 12, 2025, and what to watch next. Why BBAI is moving today Pre‑market activity. BigBear.ai was one of Nasdaq’s most‑active tickers this morning, changing hands heavily around $6.40 pre‑market, a continuation of Tuesday’s post‑earnings surge. Intraday levels are volatile, as shown above. Nasdaq Fresh analyst signals. A TipRanks AI-generated note this morning cut the price target to $5.50 and set a Neutral stance, citing mixed fundamentals despite the strategic logic of the Ask Sage deal. At the same time, aggregated Street views still
12 November 2025
 ·  ·  ·  ·  · 
Lucyd (NASDAQ: LUCY) Pops Pre‑Market as Q3 Results Are Expected Today — Rebrand, Exec Moves, and New AI Safety Glasses in Focus (Nov. 12, 2025)

Lucyd (NASDAQ: LUCY) Pops Pre‑Market as Q3 Results Are Expected Today — Rebrand, Exec Moves, and New AI Safety Glasses in Focus (Nov. 12, 2025)

Quick take: Lucyd, Inc. (formerly Innovative Eyewear) is trading sharply higher in Wednesday’s pre‑market ahead of an expected third‑quarter earnings release. Momentum follows an October corporate name change, November executive moves, and last week’s launch of new ANSI‑rated, ChatGPT‑enabled Lucyd Armor® smart‑safety glasses. PR Newswire+3TipRanks+3MarketScreener+3 What’s moving the stock today Catalyst: Q3 FY2025 results expected today Several earnings calendars show Lucyd (LUCY) slated to report Q3 2025 results before the U.S. market open on Wednesday, Nov. 12 (timing based on third‑party calendars; official company release not yet posted on the IR site at the time of publication). Watch for updates
12 November 2025
 ·  ·  ·  ·  · 
Anthropic’s Private Shares Soar to $185 Amid AI Frenzy – $183B Valuation, Major Deals & $1.5B Lawsuit

Anthropic Poised to Beat OpenAI to Profitability as It Diversifies Beyond Nvidia — What’s New Today (Nov. 12, 2025)

Key Points at a Glance What the New Profitability Forecasts Tell Us Internal projections shared with investors show starkly different roads to the black for the two most closely watched AI startups. Anthropic outlines a path to break‑even in 2028, whereas OpenAI doesn’t project profitability until 2030. The figures were surfaced in a Wall Street Journal analysis and amplified by financial outlets on Tuesday and Wednesday. Investing.com The report also describes Anthropic’s focus on enterprise customers (roughly 80% of revenue) and a leaner product mix—notably avoiding cost‑heavy image and video generation—along with a plan to compress cash burn from about
12 November 2025
 ·  ·  ·  · 
E.ON and RWE confirm 2025 outlooks as profits hold up — RWE stock pops on AI data‑centre momentum (Nov 12, 2025)

E.ON and RWE confirm 2025 outlooks as profits hold up — RWE stock pops on AI data‑centre momentum (Nov 12, 2025)

Germany’s two biggest listed utilities, E.ON and RWE, both reaffirmed their full‑year 2025 guidance today. E.ON posted higher nine‑month earnings on the back of heavy grid investment, while RWE beat profit expectations thanks to a one‑off gain from the sale of a UK data‑centre project and flagged a growing pipeline tied to AI infrastructure. Shares in RWE jumped to a fresh high in early trade. ( Reuters) Key takeaways E.ON: grid spending keeps the earnings engine humming E.ON — Europe’s largest operator of energy networks — said nine‑month investments rose about 8%, helping lift core profit by 10% year‑on‑year. The group reconfirmed 2025 adjusted
12 November 2025
 ·  ·  ·  · 
Opendoor (OPEN) today — Nov. 10, 2025: JPMorgan calls a ‘major transformation,’ while investors weigh a $1.2B note repurchase, 180.6M‑share sale, and a new tradable‑warrants dividend

Opendoor (OPEN) Pops as CEO Pledges $1M Share Purchase and Goldman Discloses 5.1% Stake — What Investors Need to Know Today (Nov. 11, 2025)

Date: November 11, 2025 Ticker: NASDAQ: OPEN At a Glance (Nov. 11) OPEN Stock Today: Price, Volume and Context By late session Tuesday, Opendoor traded near $8.48, up about 0.53 on the day, after ranging from $7.82 to $8.61. Turnover was intense, topping 224 million shares, underscoring how retail flows and headline risk continue to amplify intraday swings. U.S. equity markets were open for trading on Veterans Day (Nov. 11), though the bond market was closed — a nuance that sometimes affects liquidity and volatility profiles.  CBS News What’s Driving Opendoor Today 1) CEO Share‑Buy Pledge New CEO Kaz Nejatian said in a Monday night post that today would be the first day he’s allowed
11 November 2025
 ·  ·  ·  ·  · 
GSK (GSK) news today — Nov 11, 2025: New AN2 TB collaboration, buyback activity filed, shares test 12‑month high

GSK (GSK) news today — Nov 11, 2025: New AN2 TB collaboration, buyback activity filed, shares test 12‑month high

GSK plc (NYSE: GSK; LSE: GSK) generated several headlines today: a fresh research tie‑up in tuberculosis drug discovery, confirmation of ongoing share repurchases via a new U.K. regulatory filing, and a U.S.‑listed share price that pushed to a new 12‑month high intraday. BioSpace+2 1) New research collaboration targets TB AN2 Therapeutics announced a collaboration with GSK to advance boron‑based leucyl‑tRNA synthetase (LeuRS) inhibitors for tuberculosis. The effort is supported by a third year of Gates Foundation funding and builds on prior work between AN2 scientists and GSK’s Global Health R&D team, according to the release. Thomas Breuer, GSK’s Chief Global
11 November 2025
 ·  ·  ·  · 
Brookfield Renewable (BEP) Slides After $650M Equity Raise: Proceeds Target Isagen Stake & Baseload Growth (11/11/2025)

Brookfield Renewable (BEP) Slides After $650M Equity Raise: Proceeds Target Isagen Stake & Baseload Growth (11/11/2025)

Brookfield Renewable Partners L.P. (NYSE: BEP; TSX: BEP.UN) traded lower today after unveiling a fresh equity financing package tied to its push into “firm” clean power—including hydro and nuclear—and the recently completed increase in its stake in Colombia’s Isagen. Here’s what changed today, why it matters, and what’s next for investors. Key takeaways What happened today BEP units fell in morning trading after Monday’s after‑hours weakness, with market desks citing dilution from a new unit sale. Coverage noted the decline was linked to the US$650M capital raise unveiled the prior evening. MarketWatch+1 On the TSX, MarketWatch reported the Canadian line
11 November 2025
 ·  ·  ·  ·  · 
1 … 5 6 7 8 9 … 15
Go toTop